tocainide medication
托卡因药物
tocainide therapy
托卡因治疗
taking tocainide
服用托卡因
prescribed tocainide
开具托卡因
tocainide hydrochloride
盐酸托卡因
tocainide use
托卡因使用
tocainide treatment
托卡因疗法
tocainide dosage
托卡因剂量
discontinuing tocainide
停用托卡因
tocainide effects
托卡因疗效
tocainides are commonly prescribed for ventricular arrhythmias.
妥卡胺通常用于治疗室性心律失常。
the physician adjusted the tocainides dosage based on the patient's response to treatment.
医师根据患者对治疗的反应调整了妥卡胺的剂量。
tocainides may cause dizziness and nausea as common side effects during initial treatment.
妥卡胺在初始治疗期间可能会引起头晕和恶心等常见副作用。
regular blood monitoring is essential when administering tocainides to maintain therapeutic levels.
使用妥卡胺时定期进行血液监测对于维持治疗水平至关重要。
tocainides should not be combined with other sodium channel blocking antiarrhythmic drugs.
妥卡胺不应与其他钠通道阻滞型抗心律失常药物联合使用。
the clinical efficacy of tocainides has been demonstrated in multiple randomized trials.
妥卡胺的临床疗效已在多项随机试验中得到证实。
patients should immediately report any adverse cardiac reactions while taking tocainides.
患者在服用妥卡胺时应立即报告任何不良心脏反应。
tocainides require careful dose titration to achieve optimal antiarrhythmic effects.
妥卡胺需要仔细调整剂量以达到最佳的抗心律失常效果。
the mechanism of action of tocainides involves selective sodium channel blockade in cardiac tissue.
妥卡胺的作用机制涉及心脏组织中的选择性钠通道阻滞。
tocainides offer an effective oral alternative for patients who cannot tolerate intravenous lidocaine.
对于不能耐受静脉利多卡因的患者，妥卡胺提供了一种有效的口服替代方案。
long-term tocainides therapy necessitates periodic electrocardiogram and liver function monitoring.
长期妥卡胺治疗需要定期进行心电图和肝功能监测。
tocainides metabolism occurs primarily through hepatic pathways with renal excretion of metabolites.
妥卡胺代谢主要通过肝脏途径进行，代谢物经肾脏排泄。
the safety profile of tocainides requires careful patient selection and monitoring protocols.
妥卡胺的安全性需要仔细筛选患者并制定监测方案。
tocainide medication
托卡因药物
tocainide therapy
托卡因治疗
taking tocainide
服用托卡因
prescribed tocainide
开具托卡因
tocainide hydrochloride
盐酸托卡因
tocainide use
托卡因使用
tocainide treatment
托卡因疗法
tocainide dosage
托卡因剂量
discontinuing tocainide
停用托卡因
tocainide effects
托卡因疗效
tocainides are commonly prescribed for ventricular arrhythmias.
妥卡胺通常用于治疗室性心律失常。
the physician adjusted the tocainides dosage based on the patient's response to treatment.
医师根据患者对治疗的反应调整了妥卡胺的剂量。
tocainides may cause dizziness and nausea as common side effects during initial treatment.
妥卡胺在初始治疗期间可能会引起头晕和恶心等常见副作用。
regular blood monitoring is essential when administering tocainides to maintain therapeutic levels.
使用妥卡胺时定期进行血液监测对于维持治疗水平至关重要。
tocainides should not be combined with other sodium channel blocking antiarrhythmic drugs.
妥卡胺不应与其他钠通道阻滞型抗心律失常药物联合使用。
the clinical efficacy of tocainides has been demonstrated in multiple randomized trials.
妥卡胺的临床疗效已在多项随机试验中得到证实。
patients should immediately report any adverse cardiac reactions while taking tocainides.
患者在服用妥卡胺时应立即报告任何不良心脏反应。
tocainides require careful dose titration to achieve optimal antiarrhythmic effects.
妥卡胺需要仔细调整剂量以达到最佳的抗心律失常效果。
the mechanism of action of tocainides involves selective sodium channel blockade in cardiac tissue.
妥卡胺的作用机制涉及心脏组织中的选择性钠通道阻滞。
tocainides offer an effective oral alternative for patients who cannot tolerate intravenous lidocaine.
对于不能耐受静脉利多卡因的患者，妥卡胺提供了一种有效的口服替代方案。
long-term tocainides therapy necessitates periodic electrocardiogram and liver function monitoring.
长期妥卡胺治疗需要定期进行心电图和肝功能监测。
tocainides metabolism occurs primarily through hepatic pathways with renal excretion of metabolites.
妥卡胺代谢主要通过肝脏途径进行，代谢物经肾脏排泄。
the safety profile of tocainides requires careful patient selection and monitoring protocols.
妥卡胺的安全性需要仔细筛选患者并制定监测方案。
探索常用高频词汇